InvestorsHub Logo
Followers 6
Posts 374
Boards Moderated 0
Alias Born 03/27/2005

Re: InTheTrenches post# 846

Thursday, 03/31/2011 11:21:28 PM

Thursday, March 31, 2011 11:21:28 PM

Post# of 427037
Again, many drs see a slight increase in LDL as benign while on Lovaza because it repackages the VLDL-c. I think AMR101 can out sell lovaza, and that no cheap generic is a great thing. AMR101 may also have lovaza beat in a few key markers and NON-HDL-C. The data on the additional markers will be interesting.

I have heard experts say they are much more concerned about patients with normal LDL and high VLDL, than they are about patients with High LDL and low VLDL. Basically, even if you have normal LDL, you can still be at risk if you have high VLDL. That makes me want to run out and test my VLDL ))

amr101 4g should come in around 25% on tgs with a slight decrease, or no increase in LDL. 2g will be right around the 15%.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News